7TH-31867-29464 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-13
Dose 1 — Moderna
2021-04-10
Dose 2 — Moderna
2021-11-21
Dose 3 — Moderna
2021-11-22
Registered in v-safe
2021-11-23
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Muscle or body aches, Nausea

Adult check-in
2021-11-25
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-12-05
Health check-in — day 14, dose 3
Feeling: Fair

Adult check-in
2022-01-02
Survey response — day 42, dose 3
MedDRA: COVID-19 — Feeling: Poor · Be unable to do your normal daily activities

Free text: I have covid

MedDRA releases: 2024-11 · check-in free text available
2022-02-22
Survey response — 3 months, dose 3
MedDRA: Ageusia, Anosmia, Insomnia, Pyrexia — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Late covid symptoms: loss of smell and taste, low grade fever and insomnia

MedDRA releases: 2024-11 · check-in free text available
2022-02-22
Report sent to call center — 3 months, dose 3
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-03-21
Call successful
Participant prefers to complete VAERS report online
2022-05-22
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-13	Moderna	No
2	2021-04-10	Moderna	No
3	2021-11-21	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2022-02-22	Successful 2022-03-21	Participant prefers to complete VAERS report online

Free text

Release 10 — day 42, dose 3

2022-01-02

Symptoms: I have covid

Release 11 — 3 months, dose 3

2022-02-22

Symptoms: Late covid symptoms: loss of smell and taste, low grade fever and insomnia

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Ageusia	·	·	✓
SD	Anosmia	·	·	✓
SD	COVID-19	·	·	✓
SD	Insomnia	·	·	✓
SD	Pyrexia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release